[{"id":"b23a6436-1228-4cae-b41e-2651fbd03867","acronym":"","url":"https://clinicaltrials.gov/study/NCT03644459","created_at":"2021-01-18T17:53:31.095Z","updated_at":"2024-07-02T16:36:48.936Z","phase":"Phase 1","brief_title":"Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101","source_id_and_acronym":"NCT03644459","lead_sponsor":"Lynkcell Inc.","biomarkers":" TNFA • CRP","pipe":"","alterations":" ","tags":["TNFA • CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LYN-00101"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 04/03/2019","start_date":" 04/03/2019","primary_txt":" Primary completion: 06/01/2020","primary_completion_date":" 06/01/2020","study_txt":" Completion: 08/01/2020","study_completion_date":" 08/01/2020","last_update_posted":"2020-03-11"}]